To determine if other VEGFR1+ BMDC-enriched sites in the tumour macroenvironment (such as the lungs) favoured metastasis, the subcutaneous tumours were allowed to grow in vivo for 2 weeks to prime the tumour macroenvironment. The gene discussed is FLT1; the disease is neoplasm.